학술논문
Cost-minimisation analysis of chronic lymphocytic leukemia in Spain in the era of oral targeted therapies
Document Type
Article
Source
Farmacia Hospitalaria; March-April 2022, Vol. 46 Issue: 2 p72-79, 8p
Subject
Language
ISSN
11306343
Abstract
Chronic lymphocytic leukaemia places a considerable economic burden on the Spanish National Health System. This study estimated the direct costs of chronic lymphocytic leukaemia oral targeted therapies from 2011 to 2025, inclusive, in a scenario with fixed treatment oral targeted therapies and in a scenario without them.